Updates

Inspecs

October 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

I met with chief executive Richard Peck and finance director Christopher Kaye again after interim results. These were as anticipated with sales and EBITDA both up 6% to £111m and £12.1m, respectively. The period shows a stabilisation and the benefits of the past acquisition programme bearing fruit. In particular, Noville, which took Inspecs into lenses and has been relocated to the site in Gloucester (4x bigger), has reduced its losses from £2.1m to £1.2m this half. A new commercial director has just been appointed and with the business attracting new customers, it’s set to breakeven during H2. Meanwhile, the supply to Amazon of lenses for its “cyborg glasses” programme continues to generate consultancy income, and order volumes w ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Nexteq

Frontier Developments

Inspecs - Q1 signals the corner is turned (May 2024)

Inspecs (February 2024)

Inspecs - Margins enhanced by moving Eschenbach acetate manufacture to Vietnam (January 2024)

Inspecs (August 2023)

Inspecs - EBITDA forecast to jump US$6m this year (July 2023)

Inspecs (May 2023)

Inspecs (February 2023)

Inspecs - Interesting new issue (March 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X